Ultragenyx Pharmaceutical
RARE
#4773
Rank
โ‚น176.61 B
Marketcap
โ‚น1,828
Share price
-3.10%
Change (1 day)
-45.16%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: โ‚น176.61 Billion

As of March 2026 Ultragenyx Pharmaceutical has a market cap of โ‚น176.61 Billion. This makes Ultragenyx Pharmaceutical the world's 4773th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น176.61 B-40.36%
2025โ‚น296.11 B-13.91%
2024โ‚น343.96 B5.22%
2023โ‚น326.89 B21.63%
2022โ‚น268.77 B-37%
2021โ‚น426.62 B-36.3%
2020โ‚น669.75 B280.2%
2019โ‚น176.15 B13.92%
2018โ‚น154.62 B22.6%
2017โ‚น126.12 B-35.4%
2016โ‚น195.22 B-32.65%
2015โ‚น289.86 B226.38%
2014โ‚น88.81 B

End of Day market cap according to different sources

On Mar 27th, 2026 the market cap of Ultragenyx Pharmaceutical was reported to be:

โ‚น176.61 Billion
by Nasdaq info icon info icon
โ‚น176.61 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Lexicon Pharmaceuticals
LXRX
โ‚น65.92 B-62.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น66.36 B-62.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น426.72 B 141.62%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น981.98 B 456.01%๐Ÿ‡บ๐Ÿ‡ธ USA